The
Injectable Drug Delivery Conference returns in 2025 as a unique platform for senior technical experts from big pharma to meet and discuss the scientific aspects of parenteral drug delivery, with primary emphasis on biocompatibility, device primary packaging, extractables and leachables, and formulation development.
Attendees can also delve into the latest in drug-device interactions, sustainable materials and regulatory hot-takes, and examine cutting-edge developments within subcutaneous delivery of biologics, peptides and more.
Don't miss the chance to hear detailed case-studies from high-level big pharma experts and be involved in interactive panel discussions, examining device material selection and adoption of delivery devices for advanced modalities. This focus on technical, in-depth presentations allows for a tailored audience of device developers compared to wide and varied audience of other conferences.
This conference is poised to be a pivotal event for professionals seeking focused discussions on the latest innovations within injectable drug product development and delivery, ensuring attendees are equipped with the latest insights to drive progress in this dynamic field.
Why you should attend:
- ENGAGE in discussions on the latest innovations within complex formulations including long acting and large volume injectables with leaders from Novartis, Pfizer, and Medincell.
- GAIN insights from senior industry experts on combination product design considerations including primary packaging material choices and risk management strategies.
- UNCOVER the robust E&L and toxicology testing strategies being employed to minimize unwanted drug-device interactions through detailed case study presentations from CSL Behring, Octapharma and Biophorum.
- DISCUSS the future of sustainable device development with industry leaders from GSK, UCB Pharma, Roche and more, through an interactive panel discussion session.
- BUILD your ecosystem within Injectable Drug Delivery to uncover potential collaborators and keep pace with this rapidly advancing field.
Who should attend:
- Any company striving to optimize injectable delivery of therapies to patients in need.
- If you or your company are working on or looking to break into any of the following areas, this conference is a must!
- Combination product/parenteral drug research and development
- Vaccine R&D
- Combination product formulation
- Primary packaging and container closure integrity challenges
- Biocompatibility, extractables and leachables and toxicology testing
- Device design for advanced modalities
- Regulatory compliance for combination products
Featured Speakers
- Alicja Sobantka, Head of Corporate Material Qualification, Octapharma
- Chantal Pfaffen, Global Lead Material Qualification, CSL Behring
- Christian Proff, Senior Verification Engineer, Roche
- Claire Albert, Drug Product Team Leader & Process Scientist, Sanofi
- Clovis Pichon, Head of Device Program Leadership, UCB
- Confirmed Senior Representative, Biophorum
- Conor O'Neill, Head of Packaging Development and Design, GSK
- Estefania Dos Anjos, Senior Product Specialist, TÜV SÜD
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Jehanzeb Ahmed, Project Leader, Device Engineering, GSK
- Joel Richard, Chief Development Officer, Enterome
- Kai Zwingenberger, Medical Director Global Quality, Akamema Consulting
- Klaus Boje, Senior Scientist Primary Packaging Development, Boehringer Ingelheim
- Marion Briggs, Circular Economy Expert and Member, Alliance to Zero
- Nicola Bettini, Principal Medical Device Manufacturing Engineer, Roche
- Rachel Koppelman, Head of Device Engineering, Sandoz
- Ryan Noble, Associate Director Regulatory Affairs - CMC Devices, GSK
- Simon Dell, Device Development Lead, Pfizer
- Soroosh Bagheriasl, Phorum Director, BioPhorum
- Sylvestre Grizot, Research & Innovation Leader, MedinCell
- Tony Haythornthwaite, Device Engineering Manager, GSK
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
